WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'3301 Infant (under 12 months) mortality rate: 462
GDP / capita (US$): 3'9581 Child (under 5 years) mortality rate: 602

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 24'407  23'852  23'304  22'763  22'230  17'523  11'790  7'907 
Births 760  752  745  737  730  695  620  447 
Surviving infants 718  710  702  694  686  646  565  388 
Pop. less than 5 years 3'446  3'397  3'360  3'340  3'323  3'113  2'535  1'647 
Pop. less than 15 years 9'806  9'710  9'622  9'549  9'485  8'511  6'143  3'878 
Female 15-49 years 6'077  5'889  5'700  5'506  5'311  3'712  2'374  1'704 

Number of reported case

(Click for retrospective incidence data for Yemen)
Diphtheria 555 
Japanese encephalitis
Measles 400  2'177  2'676  510  130  18'020 
Mumps 3'837  5'081  3'306  4'685  5'243 
Pertussis 2'529  4'699  2'280  2'534  2'500  15'332 
Polio* 722 
Rubella 706  199  337  187  225 
Rubella (CRS)
Tetanus (neonatal) 66  80  38  93  30  174 
Tetanus (total) 66  115  38  93  30  405 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Yemen)
Vaccine year result method % card seen                                                
BCG 2005  69  MICS   48  69  64  59  65  58  82  100 
DTP1 2005  78  MICS   48  94  89  89  94  92  88 
DTP3 2005  61  MICS   48  88  82  81  87  86  76  89 
HepB_BD         
HepB3 2005  19  MICS   48  88  82  81  87  86  15 
Hib3 2005  43  MICS   48  88  82  81  87  86 
JapEnc         
MCV 2005  65  MICS   48  78  71  71  73  69  71  74 
MCV2          55  48  54  49  44 
PCV1          94  88  81 
PCV3          88  82  56 
Pol3 2005  63  MICS   48  88  82  81  88  86  76  89 
Rota1          79  35 
Rota_last          71  23 
Rubella1         
TT2plus 1996  DHS   31  18  13  13  17  20  31  15 
PAB         
VAD1          60  49  65  63  59 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Yemen)
BCG 71  64  59  65  58  82  95 
DTP1 94  89  89  94  92  88  94  18 
DTP3 88  82  81  87  86  76  84 
HepB3 88  82  81  87  86  15 
HepB_BD
Hib3 88  82  81  87  86 
MCV 78  71  71  73  69  71  69 
MCV2 55  48  54  49  44 
PAB 70  66  66  66  66  54  17 
PCV3 88  82  56 
Pol3 88  89  81  88  86  76  84 
Rota_last 71  23 

Number of districts in the country 333  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 42
From 80 to 89% 34
From 50 to 79% 18
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
2
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV Yes From January 2015
Measles 9, 18 months; Yes
MR Yes From June 2014
OPV birth; 6, 10, 14 weeks; 9, 18 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 9, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 306  321  306  306  333  333  333 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 333  333  333  333  333  333  333 
Nº districts with DTP3 coverage >=80% number 255  194  189  249  227  221  98 
% of districts with DTP3 coverage >=80% From 0 to 100% 77  58  57  75  68  66  29 
Nº districts with measles (MCV1) coverage >=95% number 36  22  24  20  13  21   
% of districts with MCV1 coverage >=95% From 0 to 100% 11   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 16  15    20  35  18  31 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.